Tolvaptan, an FDA-approved drug, inhibits Zika virus infection both in vitro and in vivo
Xiuxiu Chen, Ronghua Luo, Zhaiwen Yao, Changbo Zheng, Qiuju Tang, Wei Pang, Fang Wang, Liumeng Yang, Sidong Xiong, Yongtang Zheng
Journal of Chinese Pharmaceutical Sciences
.
2021, (3): 218
-229
.
DOI: 10.5246/jcps.2021.03.017
>
>